GLP-1 RA Use Associated with Lower 5-Year Mortality in Colon Cancer | Targeted Oncology

Written by

in

Use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs), commonly used for treatment and management of type 2 diabetes mellitus and obesity, was associated with reduced odds of 5-year mortality in patients with colon cancer in a study…

Continue Reading

More posts

Endoscopic submucosal dissection: a safe alternative to surgical intervention for young patients under 45 years of age with early gastric cancer. ESD vs. surgery in young EGC patients | BMC Cancer

November 22, 2025
Our Solar System is racing through space 3x faster than we thought

November 22, 2025
Temporal Patterns and Comparative Analysis of Emergency Department Utilization for Abdominal Paracentesis: Insights From the National Emergency Department Sample Data (2012-2021)

November 22, 2025
Stem cell therapy helps AMD patients see again

November 22, 2025